🇺🇸 FDA
Patent

US 11851440

Modulators of eukaryotic initiation factor 2B, compositions and methods

granted A61KA61K31/415A61K31/4164

Quick answer

US patent 11851440 (Modulators of eukaryotic initiation factor 2B, compositions and methods) held by DENALI THERAPEUTICS INC. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/415, A61K31/4164, A61K31/421, A61K31/4245